These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37913890)

  • 21. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regorafenib loaded self-assembled lipid-based nanocarrier for colorectal cancer treatment via lymphatic absorption.
    Xia D; Hu C; Hou Y
    Eur J Pharm Biopharm; 2023 Apr; 185():165-176. PubMed ID: 36870399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Use of Lipid Nanocarriers to Improve Oral Delivery of Vitamins.
    Hsu CY; Wang PW; Alalaiwe A; Lin ZC; Fang JY
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30609658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral peptide delivery: challenges and the way ahead.
    Dubey SK; Parab S; Dabholkar N; Agrawal M; Singhvi G; Alexander A; Bapat RA; Kesharwani P
    Drug Discov Today; 2021 Apr; 26(4):931-950. PubMed ID: 33444788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of advanced oral drug delivery technologies facilitating the protection and absorption of protein and peptide molecules.
    Choonara BF; Choonara YE; Kumar P; Bijukumar D; du Toit LC; Pillay V
    Biotechnol Adv; 2014 Nov; 32(7):1269-1282. PubMed ID: 25099657
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
    Banerjee S; Pillai J
    Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
    [No Abstract]   [Full Text] [Related]  

  • 27. Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.
    Shreya AB; Raut SY; Managuli RS; Udupa N; Mutalik S
    AAPS PharmSciTech; 2018 Dec; 20(1):15. PubMed ID: 30564942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polyaminoacid-based nanocarriers: a review of the latest candidates for oral drug delivery.
    Robla S; Alonso MJ; Csaba NS
    Expert Opin Drug Deliv; 2020 Aug; 17(8):1081-1092. PubMed ID: 32478584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymeric nanoparticle drug delivery technologies for oral delivery applications.
    Pridgen EM; Alexis F; Farokhzad OC
    Expert Opin Drug Deliv; 2015; 12(9):1459-73. PubMed ID: 25813361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid-based nanocarriers for the oral administration of biopharmaceutics.
    Karamanidou T; Bourganis V; Kammona O; Kiparissides C
    Nanomedicine (Lond); 2016 Nov; 11(22):3009-3032. PubMed ID: 27781558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
    Yun Y; Cho YW; Park K
    Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Challenges in Oral Drug Delivery and Applications of Lipid Nanoparticles as Potent Oral Drug Carriers for Managing Cardiovascular Risk Factors.
    Okur NÜ; Siafaka PI; Gökçe EH
    Curr Pharm Biotechnol; 2021; 22(7):892-905. PubMed ID: 32753006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Engineering strategies to enhance nanoparticle-mediated oral delivery.
    Yamanaka YJ; Leong KW
    J Biomater Sci Polym Ed; 2008; 19(12):1549-70. PubMed ID: 19017470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.
    Silva AC; Santos D; Ferreira D; Lopes CM
    Curr Med Chem; 2012; 19(26):4495-510. PubMed ID: 22834821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical nanotechnology for oral delivery of anticancer drugs.
    Mei L; Zhang Z; Zhao L; Huang L; Yang XL; Tang J; Feng SS
    Adv Drug Deliv Rev; 2013 Jun; 65(6):880-90. PubMed ID: 23220325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-Based Nanocarriers for Lymphatic Transportation.
    Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
    AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymeric Biomaterial and Lipid Based Nanoparticles for Oral Drug Delivery.
    Dilnawaz F
    Curr Med Chem; 2017; 24(22):2423-2438. PubMed ID: 27804879
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improving oral drug bioavailability with polycations?
    Schulz JD; Gauthier MA; Leroux JC
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt B):427-37. PubMed ID: 26614561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nano-strategies as Oral Drug Delivery Platforms for Treatment of Cancer: Challenges and Future Perspectives.
    Quadir SS; Saharan V; Choudhary D; Harish ; Jain CP; Joshi G
    AAPS PharmSciTech; 2022 May; 23(5):152. PubMed ID: 35606661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophobic ion-pairs and lipid-based nanocarrier systems: The perfect match for delivery of BCS class 3 drugs.
    Phan TNQ; Shahzadi I; Bernkop-Schnürch A
    J Control Release; 2019 Jun; 304():146-155. PubMed ID: 31075345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.